Schering-Plough's animal products sale cleared by European Commission
This article was originally published in Scrip
The European Commissionhas cleared the sale of a number ofSchering-Plough's animal health products toPfizer. Schering-Plough is selling the products as part of anti-trust commitments when it acquired Organon Biosciences from Akzo Nobel. The products include animal vaccines and parasiticides.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
The European Commission has extended the indications for Janssen’s Tremfya to include psoriatic arthritis, and those for BMS’s Opdivo to include gastroesophageal cancer.